Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

Edinburgh installs new veterinary linear accelerator
The new accelerator is equipped to deliver the most advanced forms of radiation therapy.

Advanced therapy offers new cancer treatment options

The University of Edinburgh’s Royal (Dick) School of Veterinary Studies has announced the introduction of a new linear accelerator, placing it at the forefront of veterinary cancer treatment in Europe.


The new accelerator is designed to provide more targeted treatment, meaning that higher doses of radiation can be given less frequently. It also means that patients can have a shorter stay in hospital and receive fewer anaesthetics.


Offering the same cutting edge treatment options you will find in any human hospital, the accelerator is equipped to deliver the most advanced forms of radiation therapy. This includes static gantry intensity-modulated radiation therapy (IMRT), dynamic gantry IMRT/RarpidArc, electron therapy and conventional 3D radiation therapy. 


It will be operated by a team including American and European boarded veterinary radiation oncologist Dr Magdalena Parys, European board certified oncologist Juan Carlos Serra, and therapeutic radiographer Emma McCormick. 


The University said in a press release: “IMRT is an advanced treatment technique, which allows the delivery of a precise dose of treatment to almost any tumour shape. In particular cases, this technique reduces the dose to normal structures, which decreases side effects in normal tissues which are close to the tumour. 


“Secondly, can IMRT allow an increased total dose of radiation to be delivered to the tumour. A common example is the use of IMRT to spare the eyes, brain, skin and oral cavity when treating nasal tumours. R(D)SVS is the only place in the UK to offer IMRT.”


The accelerator is also equipped with cone-beam CT imaging facilities, which enables the radiation oncologist to position the animal with greater accuracy so that treatment is safer and more effective. It is the only veterinary linear accelerator UK with this capability. 


The University added: "The new radiation unit will also soon be able to treat patients with stereotactic radiotherapy. This is a type of protocol that usually consists of one, two or three high-dose radiotherapy fractions, delivered with pin-point accuracy and in a short period of time. 


“By giving much more targeted treatment you can give high doses less frequently as you are mainly hitting the tumour cells, not the adjacent normal tissues. It also means a shorter stay in the hospital and less anaesthetics. This type of radiotherapy treatment modality has been successfully implemented in other places in the world for many tumour types, such as nasal and brain tumours.”

Image (C) University of Edinburgh.

 

Become a member or log in to add this story to your CPD history

Practices urged to audit neutering data

News Story 1
 RCVS Knowledge has called on vet practices to audit their post-operative neutering outcomes.

It follows the release of the 2024 NASAN benchmarking report, which collates data from neutering procedures performed on dogs, cats and rabbits.

The benchmarking report enables practices in the UK and Ireland to compare their post-operative outcomes to the national average. This includes the rate of patients lost to follow-up, which in 2024 increased to 23 per cent.

Anyone from the practice can submit the data using a free template. The deadline for next report is February 2026.

Visit the RCVS Knowledge website to complete an audit. 

Click here for more...
News Shorts
New guidance for antibiotic use in rabbits

New best practice guidance on the responsible use of antibiotics in rabbits has been published by the BSAVA in collaboration with the Rabbit Welfare Association & Fund (RWA&F).

The guidance is free and has been produced to help veterinary practitioners select the most appropriate antibiotic for rabbits. It covers active substance, dose and route of administration all of which are crucial factors when treating rabbits owing to the risk of enterotoxaemia.

For more information and to access the guide, visit the BSAVALibrary.